Armbruster Capital Management’s Quest Diagnostics DGX Stock Holding History

Armbruster Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-600	Closed	-$60K	–	105
2018 Q1	$60K	Hold	600	–	–	0.03%	118
2017 Q4	$59K	Hold	600	–	–	0.03%	124
2017 Q3	$56K	Hold	600	–	–	0.03%	122
2017 Q2	$67K	Hold	600	–	–	0.04%	115
2017 Q1	$59K	Hold	600	–	–	0.03%	119
2016 Q4	$55K	Sell	600 -100	-14%	-$8.62K	0.03%	120
2016 Q3	$59K	Hold	700	–	–	0.04%	115
2016 Q2	$57K	Sell	700 -8	-1%	-$609	0.04%	117
2016 Q1	$51K	Buy	708 +8	+1%	+$537	0.03%	123
2015 Q4	$50K	Buy	+700	New	+$47.1K	0.04%	126

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Armbruster Capital Management's DGX Position: Q2 2018 in Review

Armbruster Capital Management sold out of Quest Diagnostics (DGX) in Q2 2018, closing a stake of 600 shares — an estimated $60K sold.

Armbruster Capital Management first reported a position in DGX in Q4 2015 and held it in 10 quarters. The position peaked at $67K in Q2 2017. 662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

Armbruster Capital Management reported no remaining Quest Diagnostics position as of Q2 2018 after selling out during the quarter.
Armbruster Capital Management sold 600 Quest Diagnostics shares in Q2 2018, an estimated $60K.
Armbruster Capital Management first reported a position in Quest Diagnostics in Q4 2015 and held it in 10 quarters.
Armbruster Capital Management's Quest Diagnostics position peaked at $67K in Q2 2017.
662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on Armbruster Capital Management's 13F filing for Q2 2018, filed 30 Jul 2018.